Charlotta Grånäs
Novo Nordisk (Denmark) · 14 works · 549 citations · h-index 11
Top works
- N-terminal Truncation of the Dopamine Transporter Abolishes Phorbol Ester- and Substance P Receptor-stimulated Phosphorylation without Impairing Transporter Internalization
- Identification of Intracellular Residues in the Dopamine Transporter Critical for Regulation of Transporter Conformation and Cocaine Binding
- Syntheses and antiproliferative evaluation of oxyphenisatin derivatives
- Re-evaluation of the prolactin receptor expression in human breast cancer
- High Content Screening for G Protein-Coupled Receptors Using Cell-Based Protein Translocation Assays
- Identification of RAS-Mitogen-Activated Protein Kinase Signaling Pathway Modulators in an ERF1 Redistribution® Screen
- Identification of an amino acid residue important for binding of methiothepin and sumatriptan to the human 5-HT1B receptor
- Mutagenesis of the Human 5-HT1BReceptor: Differences from the Closely Related 5-HT1AReceptor and the Role of Residue F331 in Signal Transduction
- Synthetic strategies to prepare 2-alkyl, 2-aryl and 2-acetylenyl substituted 4,6-diamino-1,3,5-triazines
- Site-directed mutagenesis of the human 5-HT1B receptor
- Differential distribution of glutamate decarboxylase-65 and glutamate decarboxylase-67 messenger RNAs in the entopeduncular nucleus of the rat
- Site-directed mutagenesis of the 5-HT1B receptor increases the affinity of 5-HT for the agonist low-affinity conformation and reduces the intrinsic activity of 5-HT
- Receptor-ligand interactions of the human 5-HT[1B] receptor : a site-directed mutagenesis study
- Identification of intracellular residues in the dopamine transporter critical for regulation of transporter conformation and cocaine binding. VOLUME 279 (2004) PAGES 3228-3238